Skip to main content

Advertisement

SpringerLink
Log in

Is Parathyroid Hormone a Therapeutic Option for Osteoporosis? A Review of the Clinical Evidence

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract.

Most of the data on the anabolic effect of PTH have been obtained with hPTH(1-34). Studies have shown a marked increment in spinal bone mass. Most recently we have shown that PTH and estrogen can be given together where there is increased total bone mineral and no loss of bone at any skeletal site. We have also shown the first reduction in vertebral deformity incidence due to PTH treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Clinical Research Center, Helen Hayes Hospital, West Haverstraw, New York 10993 and Department of Medicine, Columbia Presbyterian Medical Center, New York, New York 10032, USA, , , , , , US

    F. Cosman & R. Lindsay

Authors
  1. F. Cosman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Lindsay
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 24 June 1997 / Accepted: 8 January 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cosman, F., Lindsay, R. Is Parathyroid Hormone a Therapeutic Option for Osteoporosis? A Review of the Clinical Evidence. Calcif Tissue Int 62, 475–480 (1998). https://doi.org/10.1007/s002239900464

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002239900464

Search

Navigation